The ResIn study has published a new paper that covers all 17 years of the UK dataset so far (1997-2013) and compiled some new metrics describing the comparisons between disease burden and amount of research funding going towards specific infectious diseases. We find, for example, that some of the neglected tropical diseases continue to be well-funded and could probably be described as a UK research strength; influenza also comes out well in our analysis thanks to relatively recent large investments in respiratory research. Conversely, there is still little funding available for some non-HIV sexually-transmitted infections such as gonorrhoea and syphilis.
The full paper is open access, published in EBioMedicine. Click here for the manuscript.
Head MG, Fitchett JR, Nageshwaran V, Kumari N, Hayward AC, Atun R. Research investments in global health: a systematic analysis of UK infectious disease research funding and global health metrics, 1997-2013. EBioMedicine. 2015. doi:10.1016/j.ebiom.2015.12.016